Market by Device Type, Application, Detection and Prediction Device Type, End-user, and Country Outlook | Forecast 2022-2028
According to Triton’s report, the epilepsy devices market in Europe is expected to witness growth at a CAGR of 7.94% during the forecasting years 2022-2028.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries studied in the region comprise:
•
The United Kingdom
•
Germany
•
France
•
Spain
•
Italy
•
Rest of Europe
Germany
holds the majority of the shares in the region’s market. The increasing geriatric population prone to
epilepsy, reimbursement framework, and technological advancement in therapeutic
devices are estimated to support epilepsy monitoring device demand. Besides
this, the developed healthcare infrastructure and research funds from the
governments create numerous opportunities for manufacturers in the market.
Therefore, as stated above, these factors are anticipated to majorly drive the
epilepsy devices market over the forecast period.
In Germany, the foundation of the healthcare
system is the specialists and general practitioners. Specialized hospital
outpatient clinics like epilepsy centers offer high-level medical care to
critically ill patients. For instance, the Epilepsy Center Frankfurt Rhine-Main
conducts pre-surgical evaluations for drug-refractory epilepsy, offering
inpatient care to over 50,000 people yearly. Additionally, a 5% year-on-year
increase in injuries during accidents has elevated the risk of epilepsy
seizures due to traumatic brain injury. Thus, the rise in epilepsy cases is
anticipated to widen the epilepsy devices market’s scope.
Furthermore, brain trauma, alcohol abuse, and
cerebrovascular disorders are major factors increasing epilepsy monitoring
devices demand in France. Estimates indicate the prevalence of epilepsy has
increased among the older generation, which is another factor contributing to
the epilepsy devices market’s development.
Around 30-40% of the patients are refractory to
medication, also known as intractable epilepsy. While respective or ablative is
a beneficial procedure, it is not an option for various people due to
neurologic risk. In this regard, responsive neurostimulation is a
cortically-based stimulator activated by electrocorticography patterns. The market’s development is determined based
on application, end-user, device type, and detection and prediction device
type. The application segment is further categorized into responsive
neurostimulation, accelerometer, vagus nerve stimulation, and deep brain
stimulation.
The
prominent companies in the given market include LivaNova Plc, Cadwell
Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Natus Medical
Incorporated.
LivaNova Plc is a global medical technology
company providing products and therapies for the brain and heart. Its diverse
portfolio includes therapeutic medication for advanced circulatory support,
cardiopulmonary, drug-resistant epilepsy, and obstructive sleep apnea. The
company serves clients across healthcare systems in multiple regions. LivaNova
is headquartered in London, United Kingdom.
Key deliverables of the report:
● Market CAGR during the forecasting years 2022-2028
● Detailed data highlighting key insights, industry components, and market strategies
● Comprehensive information and estimation of the epilepsy devices market revenue growth in Europe and its influence on the parent market
● In-depth study of forthcoming trends in consumer behavioral patterns
● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the Europe
epilepsy devices market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
EPILEPSY DEVICES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE EPILEPSY DEVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. GROWING
USE OF TELEMEDICINE SERVICES
2.2.2. INCREASE
IN DRUG AND DEVICE TRIALS FOR EPILEPSY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. COMFORT
& USABILITY
2.4.2. PRODUCT
FEATURES
2.4.3. CONFIDENTIALITY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. DEVELOPMENTS
& PRODUCT LAUNCHES
2.9.2. COLLABORATIONS
2.9.3. ACQUISITIONS
2.10. MARKET
DRIVERS
2.10.1. COMBATING
EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS
2.10.2. RISING
PREVALENCE OF EPILEPSY
2.11. MARKET
CHALLENGES
2.11.1. UNAWARENESS
ABOUT EPILEPSY AMONG THE GENERAL MASSES
2.11.2. LACK OF NEUROLOGY
SPECIALISTS IN THE HEALTHCARE SYSTEM
2.12. MARKET
OPPORTUNITIES
2.12.1. R&D ACTIVITIES DUE
TO GROWING EPILEPSY CASES IN OLD PEOPLE
2.12.2. ASCENDING
POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES
2.12.3. TECHNOLOGICAL
ADVANCES IN NON-INVASIVE WEARABLE SENSORS
3. EUROPE
EPILEPSY DEVICES MARKET OUTLOOK - BY DEVICE TYPE
3.1. TRADITIONAL
DEVICES
3.2. WEARABLE
DEVICES
3.2.1. WATCHES
3.2.2. BRACELETS
3.2.3. CAMERA
DEVICES
3.2.4. MATTRESS
DEVICES
3.2.5. ANTI-SUFFOCATION
PILLOWS
3.2.6. OTHER
WEARABLE DEVICES
3.3. IMPLANTABLE
DEVICES
4. EUROPE
EPILEPSY DEVICES MARKET OUTLOOK - BY APPLICATION
4.1. VAGUS
NERVE STIMULATION
4.2. DEEP
BRAIN STIMULATION
4.2.1. MOVEMENT
DISORDERS
4.2.2. EPILEPSY
4.3. ACCELEROMETER
4.4. RESPONSIVE
NEUROSTIMULATION
5. EUROPE
EPILEPSY DEVICES MARKET OUTLOOK - BY DETECTION AND PREDICTION DEVICE TYPE
5.1. ELECTROENCEPHALOGRAM
5.2. INTRACRANIAL
EEG
5.3. SURFACE
ELECTROMYOGRAPHY
5.4. ELECTROCARDIOGRAPHY
5.5. VIDEO
DETECTION SYSTEMS
5.6. ELECTRODERMAL
ACTIVITY
5.7. IMPLANTED
ADVISORY SYSTEMS
5.8. OTHER
DETECTION AND PREDICTION DEVICE TYPES
6. EUROPE
EPILEPSY DEVICES MARKET OUTLOOK - BY END-USER
6.1. HOSPITALS
& CLINICS
6.2. NEUROLOGY
CENTERS
6.3. HOMECARE
SETTINGS
6.4. OTHER
END-USERS
7. EUROPE
EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK
7.1. UNITED
KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. ITALY
7.5. SPAIN
7.6. REST
OF EUROPE
8. COMPETITIVE
LANDSCAPE
8.1. LIVANOVA
PLC
8.2. NATUS
MEDICAL INCORPORATED
8.3. CADWELL
INDUSTRIES INC
8.4. NIHON
KOHDEN CORPORATION
8.5. COMPUMEDICS
LIMITED
8.6. MEDTRONIC
PLC
8.7. BOSTON
SCIENTIFIC CORPORATION
8.8. EMPATICA
INC
8.9. KONINKLIJKE
PHILIPS NV
8.10. NEUROPACE
INC
8.11. DRÄGERWERK
AG & CO KGAA
8.12. SHENZHEN
MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
8.13. NEUROSOFT
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE EPILEPSY
DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF
COLLABORATIONS
TABLE 6: LIST OF ACQUISITIONS
TABLE 7: EXAMPLES OF
ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES
TABLE 8: EXAMPLE OF MOBILE EEG
DEVICES
TABLE 9: EUROPE EPILEPSY
DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: EUROPE EPILEPSY
DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)
TABLE 11: EUROPE EPILEPSY
DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 12: EUROPE EPILEPSY
DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)
TABLE 13: EUROPE EPILEPSY
DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $
MILLION)
TABLE 14: EUROPE EPILEPSY
DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE EPILEPSY
DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)
FIGURE
5: EUROPE EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
6: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
7: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)
FIGURE
8: EUROPE EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)
FIGURE
9: EUROPE EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)
FIGURE
10: EUROPE EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)
FIGURE
11: EUROPE EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
12: EUROPE EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN
$ MILLION)
FIGURE
13: EUROPE EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
14: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $
MILLION)
FIGURE
15: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE
16: EUROPE EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $
MILLION)
FIGURE
17: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $
MILLION)
FIGURE
18: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028
(IN %)
FIGURE
19: EUROPE EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $
MILLION)
FIGURE
20: EUROPE EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)
FIGURE
21: EUROPE EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)
FIGURE
22: EUROPE EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028
(IN $ MILLION)
FIGURE
23: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE,
2021 & 2028 (IN %)
FIGURE
24: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $
MILLION)
FIGURE
25: EUROPE EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $
MILLION)
FIGURE
26: EUROPE EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN
$ MILLION)
FIGURE
27: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $
MILLION)
FIGURE
28: EUROPE EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $
MILLION)
FIGURE
29: EUROPE EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $
MILLION)
FIGURE
30: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028
(IN $ MILLION)
FIGURE
31: EUROPE EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE
TYPES, 2022-2028 (IN $ MILLION)
FIGURE
32: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE
33: EUROPE EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $
MILLION)
FIGURE
34: EUROPE EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $
MILLION)
FIGURE
35: EUROPE EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $
MILLION)
FIGURE
36: EUROPE EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $
MILLION)
FIGURE
37: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE
38: UNITED KINGDOM EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
39: GERMANY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
40: FRANCE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
41: ITALY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
42: SPAIN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
43: REST OF EUROPE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)